A dietary supplement that is a mixture of DT56a (a tofu extract) and flaxseed powder, that may act as a selective estrogen receptor modulator (SERM)

----------------------------------------------

Menopause, although a natural phenomena in a woman's life, is very often accompanied by disturbing symptoms in the form of vasomotor, psychological and metabolic complaints, as well as significant health issues such as vaginal atrophy, cardiovascular diseases and bone loss leading to osteopenia and osteoporosis.

The barrage of publications pointing to increased health risks associated with hormone therapy has caused an upheaval in the women's health sector. As a result, a large gap has opened up in the provision of safe solutions for the integrative therapy of menopausal symptoms and bone health.

Slowing the process of bone loss while alleviating menopausal symptoms requires a therapy that targets the physiological mechanisms affected by estrogen. For such a therapy to be safe, however, it must be selective.

The ultimate therapeutic concept for fulfilling these needs is a novel Selective Estrogen Receptor Module (SERM) that affects estrogen receptors only in specific sites, without affecting tissues where any change can have unwelcome consequences
A dietary supplement that is a mixture of DT56a (a tofu extract) and flaxseed powder, that may act as a selective estrogen receptor modulator (SERM)

----------------------------------------------

Menopause, although a natural phenomena in a woman's life, is very often accompanied by disturbing symptoms in the form of vasomotor, psychological and metabolic complaints, as well as significant health issues such as vaginal atrophy, cardiovascular diseases and bone loss leading to osteopenia and osteoporosis.

The barrage of publications pointing to increased health risks associated with hormone therapy has caused an upheaval in the women's health sector. As a result, a large gap has opened up in the provision of safe solutions for the integrative therapy of menopausal symptoms and bone health.

Slowing the process of bone loss while alleviating menopausal symptoms requires a therapy that targets the physiological mechanisms affected by estrogen. For such a therapy to be safe, however, it must be selective.

The ultimate therapeutic concept for fulfilling these needs is a novel Selective Estrogen Receptor Module (SERM) that affects estrogen receptors only in specific sites, without affecting tissues where any change can have unwelcome consequences
Medicine image

Products

Medicine image

Products


All Rights Reserved 2019